Literature DB >> 30502264

Murine Models of Intraperitoneal Perfusion for Disseminated Colorectal Cancer.

Eleanor McCabe-Lankford1, Margarita Peterson1, Bryce McCarthy1, April J Brown1, Brad Terry1, Laura Galarza-Paez1, Nicole Levi-Polyachenko2.   

Abstract

BACKGROUND: Reproduction of the perfusion used in therapy (hyperthermic intraperitoneal chemotherapy) procedures preclinically represents a valuable asset for investigating new therapeutic agents that may improve patient outcomes. This article provides technical descriptions of our execution of closed and open "coliseum" abdominal perfusion techniques in a mouse model of peritoneal carcinomatosis of colorectal cancer.
MATERIALS AND METHODS: BALB/c mice presenting with disseminated colorectal cancer (CT26-luciferin cells) underwent 30-min perfusions mimicking either the closed perfusion or the coliseum perfusion technique. Disease burden was monitored by bioluminescence signaling using an in vivo imaging system. Perfusion circuits consisted of single inflow lines with either a single or dual outflow line.
RESULTS: Twelve mice presenting with disseminated disease underwent the closed perfusion technique. Surgical complications included perfusate leakage and organ constriction/suction into the outflow line(s). Nine mice underwent the coliseum perfusion technique with surgical debulking, using bipolar cauterization to remove tumors attached to the peritoneum. All mice survived the coliseum perfusion with limited intraoperative complications.
CONCLUSIONS: Fewer intraoperative complications were experienced with our coliseum perfusion technique than the closed perfusion. The methods described here can be used as a guideline for developing future perfusion murine models for investigating perfusion models useful for delivery of chemotherapy or other tumor-sensitization agents, including selective targeted agents, nanoparticles, and heat.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Colorectal cancer; Intraabdominal perfusion; Murine model; Peritoneal carcinomatosis

Mesh:

Substances:

Year:  2018        PMID: 30502264      PMCID: PMC9121690          DOI: 10.1016/j.jss.2018.07.063

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.417


  49 in total

Review 1.  Management of peritoneal carcinomatosis from colorectal cancer.

Authors:  Chukwuemeka U Ihemelandu; Perry Shen; John H Stewart; Konstantinos Votanopoulos; Edward A Levine
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

Review 2.  Peritoneal transport physiology: insights from basic research.

Authors:  M F Flessner
Journal:  J Am Soc Nephrol       Date:  1991-08       Impact factor: 10.121

Review 3.  Firefly luciferase as a tool in molecular and cell biology.

Authors:  S J Gould; S Subramani
Journal:  Anal Biochem       Date:  1988-11-15       Impact factor: 3.365

4.  Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies.

Authors:  P H Sugarbaker; T Graves; E A DeBruijn; W J Cunliffe; R E Mullins; W E Hull; L Oliff; P Schlag
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

5.  Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.

Authors:  J L Speyer; J M Collins; R L Dedrick; M F Brennan; A R Buckpitt; H Londer; V T DeVita; C E Myers
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

6.  Thermal sensitization using induced oxidative stress decreases tumor growth in an in vivo model of hyperthermic intraperitoneal perfusion.

Authors:  Reza Razavi; Lawrence E Harrison
Journal:  Ann Surg Oncol       Date:  2009-08-27       Impact factor: 5.344

7.  Peritonectomy procedures.

Authors:  P H Sugarbaker
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

8.  Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes.

Authors:  Nicole H Levi-Polyachenko; Eric J Merkel; Bradley T Jones; David L Carroll; John H Stewart
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

Review 9.  A simple practice guide for dose conversion between animals and human.

Authors:  Anroop B Nair; Shery Jacob
Journal:  J Basic Clin Pharm       Date:  2016-03

10.  A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.

Authors:  F Aarts; T Hendriks; O C Boerman; M J Koppe; W J G Oyen; R P Bleichrodt
Journal:  Ann Surg Oncol       Date:  2007-07-25       Impact factor: 5.344

View more
  2 in total

1.  Binding of Targeted Semiconducting Photothermal Polymer Nanoparticles for Intraperitoneal Detection and Treatment of Colorectal Cancer.

Authors:  Eleanor McCabe-Lankford; Bryce McCarthy; Margarita Arakelyan-Peters Berwick; Kiarash Salafian; Laura Galarza-Paez; Santu Sarkar; John Sloop; George Donati; April J Brown; Nicole Levi-Polyachenko
Journal:  Nanotheranostics       Date:  2020-03-26

2.  Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin.

Authors:  Yin Tao; Xue-Ting Tang; Xing Li; An-Shan Wu; Hou-Shen Zhou; Cheng-Fang Zhou
Journal:  Front Med (Lausanne)       Date:  2022-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.